AWE
CVS icon

Avidian Wealth Enterprises’s CVS Health CVS Stock Holding History

Avidian Wealth Enterprises’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$755K Buy
7,300
+609
+9% +$54.4K 0.02% 387
2026
Q1 		$481K Buy
6,691
+154
+2% +$11.9K 0.02% 444
2025
Q4 		$519K Buy
6,537
+252
+4% +$19.9K 0.02% 365
2025
Q3 		$474K Buy
6,285
+214
+4% +$14.7K 0.02% 378
2025
Q2 		$419K Buy
6,071
+3,038
+100% +$199K 0.02% 375
2025
Q1 		$205K Buy
+3,033
New +$182K 0.01% 498
2024
Q2 		– Sell
-2,971
Closed -$237K – 506
2024
Q1 		$237K Buy
2,971
+272
+10% +$20.8K 0.01% 393
2023
Q4 		$213K Sell
2,699
-963
-26% -$68.5K 0.01% 393
2023
Q3 		$256K Sell
3,662
-1,114
-23% -$78.9K 0.02% 349
2023
Q2 		$330K Sell
4,776
-1,640
-26% -$117K 0.02% 328
2023
Q1 		$477K Buy
6,416
+867
+16% +$72.7K 0.03% 303
2022
Q4 		$517K Sell
5,549
-43
-0.8% -$4.15K 0.03% 270
2022
Q3 		$533K Sell
5,592
-213
-4% -$21.1K 0.04% 227
2022
Q2 		$538K Sell
5,805
-4,253
-42% -$415K 0.04% 252
2022
Q1 		$1.02M Sell
10,058
-9
-0.1% -$945 0.06% 193
2021
Q4 		$1.04M Buy
10,067
+6,374
+173% +$589K 0.06% 181
2021
Q3 		$313K Buy
3,693
+441
+14% +$36.9K 0.02% 287
2021
Q2 		$271K Buy
3,252
+221
+7% +$18.1K 0.02% 326
2021
Q1 		$228K Sell
3,031
-190
-6% -$13.8K 0.02% 325
2020
Q4 		$220K Buy
+3,221
New +$210K 0.02% 287
2020
Q1 		– Sell
-2,782
Closed -$207K – 220
2019
Q4 		$207K Buy
+2,782
New +$195K 0.03% 218

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Avidian Wealth Enterprises's CVS Position: Q2 2026 in Review

Avidian Wealth Enterprises increased its CVS Health (CVS) stake by 9.1% in Q2 2026, buying an estimated $54.4K and bringing the position to 7,300 shares worth $755K. The position accounts for 0.02% of the portfolio, ranked #387.

Avidian Wealth Enterprises first reported a position in CVS in Q4 2019 and has held it in 21 quarters since. The position peaked at $1.04M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Avidian Wealth Enterprises held 7,300 shares of CVS Health worth $755K as of Q2 2026.
  • Avidian Wealth Enterprises bought 609 CVS Health shares in Q2 2026, an estimated $54.4K.
  • CVS Health made up 0.02% of Avidian Wealth Enterprises's portfolio in Q2 2026, its #387 holding.
  • Avidian Wealth Enterprises first reported a position in CVS Health in Q4 2019 and has held it in 21 quarters since.
  • Avidian Wealth Enterprises's CVS Health position peaked at $1.04M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Avidian Wealth Enterprises's 13F filing for Q2 2026, filed 24 Jul 2026.